Evidence map›Paper›PMID 31739602›Full record

ArticleMicroorganisms2019

Mapping Epitopes of a Novel Peptidoglycan Cross-Linking Enzyme Cwp22 Recognized by Human Sera Obtained from Patients with

Agnieszka Razim, Katarzyna Pacyga, Gajane Martirosian, Andrzej Szuba, Andrzej Gamian, Andrzej Myc, Sabina Górska

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Non-Toxin-BasedPathogens (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Editorial for the Special Issue:Microorganisms · 2021
    Article
  4. Host Immune Responses toFrontiers in microbiology · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Agnieszka RazimDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Katarzyna PacygaDepartment of Microbiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Gajane MartirosianDepartment of Medical Microbiology, School of Medicine in Katowice, Medical University of Silesia, 40752 Katowice, Poland.
Andrzej SzubaDivision of Angiology, Wroclaw Medical University, 51-618 Wroclaw, Poland.
Andrzej GamianDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Andrzej MycDepartment of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Sabina GórskaDepartment of Microbiology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PLMedical University of Silesia · PLUniversity of Michigan · USWroclaw Medical University · PL

Funding

Narodowe Centrum Nauki 2016/21/B/NZ6/02286
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

epitopepeptidesurface proteinvaccine

Identifiers

PMID31739602
PMCPMC6920951
OpenAlexW2984267584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.